Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.71
+0.06 (0.78%)
At close: Nov 18, 2025, 4:00 PM EST
7.71
0.00 (0.00%)
After-hours: Nov 18, 2025, 7:00 PM EST
Organon & Co. Stock Forecast
Stock Price Forecast
The 4 analysts that cover Organon & Co. stock have a consensus rating of "Hold" and an average price target of $15.75, which forecasts a 104.28% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $24.
Price Target: $15.75 (+104.28%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell Maintains $14 → $12 | Sell | Maintains | $14 → $12 | +55.64% | Nov 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +16.73% | Nov 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $24 → $18 | Buy | Maintains | $24 → $18 | +133.46% | May 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $10 | Hold | Maintains | $15 → $10 | +29.70% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +94.55% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
6.35B
from 6.40B
Decreased by -0.80%
Revenue Next Year
6.39B
from 6.35B
Increased by 0.65%
EPS This Year
3.89
from 3.33
Increased by 16.73%
EPS Next Year
4.08
from 3.89
Increased by 4.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.6B | 6.7B | |||
| Avg | 6.4B | 6.4B | |||
| Low | 6.1B | 6.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.7% | 5.7% | |||
| Avg | -0.8% | 0.6% | |||
| Low | -4.2% | -4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.11 | 4.47 | |||
| Avg | 3.89 | 4.08 | |||
| Low | 3.62 | 3.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.3% | 15.1% | |||
| Avg | 16.7% | 5.0% | |||
| Low | 8.6% | -6.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.